Skip to main content
Premium Trial:

Request an Annual Quote

Dow, Synpromics Collaborate on Synthetic Promoter Development

NEW YORK (GenomeWeb News) –Dow AgroSciences will develop synthetic promoter firm Synpromics' technology for applications in plant science under a collaboration announced today.

An initial proof of concept project with Dow Agro has begun to demonstrate the applicability of Synpromics' technology in certain crops, Synpromics said. Financial and other terms of the deal were not disclosed.

"Technologies such as those developed by Synpromics can significantly enhance Dow AgroSciences' tool kit for developing improved crops," Daniel Kittle, vice president of R&D for Dow AgroSciences, said in a statement. "Synthetic promoters in the agricultural industry have significant potential to accelerate the gene discovery and product development of new traits."

Based in Edinburgh, Scotland, Synpromics develops synthetic promoters for applications in diagnostics development, gene therapeutics, and research use. A synthetic promoter is a regulatory DNA sequence created by picking out the regulatory regions in a gene, chopping them up, and then putting them back together.

Filed under

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.